Crossref
The Prognostic Role of Serum Human Epidermal Growth Factor Receptor (HER2) in Metastatic Breast Cancer Patients.
SECI Oncology Journal · 18.08.2026 · 14 (3) · 144-152
DOI: 10.21608/secioj.2026.523064 ↗Kurz gefasst
Fachartikel in der Zeitschrift SECI Oncology Journal, online erschienen am 18.08.2026.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). The Prognostic Role of Serum Human Epidermal Growth Factor Receptor (HER2) in Metastatic Breast Cancer Patients. SECI Oncology Journal, 14(3), 144-152. https://doi.org/10.21608/secioj.2026.523064
Vancouver
The Prognostic Role of Serum Human Epidermal Growth Factor Receptor (HER2) in Metastatic Breast Cancer Patients. SECI Oncology Journal. 2026;14(3):144-152. doi:10.21608/secioj.2026.523064
BibTeX
@article{euvimed2026,
title = {The Prognostic Role of Serum Human Epidermal Growth Factor Receptor (HER2) in Metastatic Breast Cancer Patients},
journal = {SECI Oncology Journal},
year = {2026},
volume = {14},
number = {3},
pages = {144--152},
doi = {10.21608/secioj.2026.523064}
}
EUVIMED